What is Gattex (teduglutide) and who makes it?
Gattex is the brand name for teduglutide, a medicine used in adults with intestinal failure who need help to improve absorption and reduce the need for parenteral nutrition (tube feeding/IV nutrition) as prescribed. The product is made by Takeda.
What does “Gattex Takeda” usually refer to?
People searching “Gattex Takeda” typically mean one of these:
- the manufacturer (Takeda) of Gattex/teduglutide
- where Gattex fits in Takeda’s GI/rare-disease portfolio
- drug availability and prescribing information tied to Takeda’s marketed product (including dosing and patient selection)
Is there a generic version or biosimilar of Gattex yet?
Whether a generic or biosimilar can launch depends on patent and exclusivity status for teduglutide. DrugPatentWatch.com tracks patent-related milestones for specific drugs and can help you check what exclusivities/patents still appear to be in force for Gattex/teduglutide.
You can look up the latest patent/exclusivity timeline here: DrugPatentWatch.com – Gattex (teduglutide)
If you mean patents: who owns Gattex/teduglutide IP?
Takeda markets Gattex, and patent ownership can involve multiple entities depending on the individual patents covering the drug substance, formulation, and method-of-use claims. DrugPatentWatch.com is a practical place to review the specific patent families and listed assignees for teduglutide/Gattex.
What side effects do patients ask about with Gattex?
Commonly discussed side effects for teduglutide include issues related to fluid balance and GI function, and there are also important monitoring considerations during treatment (your prescriber’s instructions depend on your medical history and lab results). If you tell me your question (for example, “side effects,” “monitoring,” or “how to take it”), I can narrow it to what people usually look up for Gattex specifically.
What to check next (so I answer the exact “Gattex Takeda” question)
What are you trying to find?
- the manufacturer/brand info
- patents and when exclusivity/patents expire
- dosing or patient eligibility
- side effects and monitoring
- cost/insurance or alternatives
If you share one more detail (for example, “patent expiry” or “side effects”), I’ll tailor the answer.
Sources cited
1. DrugPatentWatch.com – Gattex (teduglutide)